Background Previous studies have documented the high patient and caregiver burden
associated with atopic dermatitis (AD). Less is known about the factors—especially those related …

Importance Atopic dermatitis (AD) is long term and burdensome. Studies investigating disease
burden in adults are limited in scope with gaps in understanding of the adult patient lived …

As use of PD-1 inhibitors increases, we will have greater opportunity to observe this
phenomenon of a possible epidermal–high dermal privileged tumour microenvironment. It will be …

Background Individuals with eczema may have substantial lifetime corticosteroid exposure,
increasing the risk of corticosteroid-related side effects. Objective To conduct a patient …

DEAR EDITOR, Family caregivers are essential to the wellbeing of individuals with chronic
health conditions. However, they often experience psychological, behavioural and …

The treatment pipeline for eczema is flush with new options that stand to transform care and
quality of life for people who live with eczema. During this time of rapid change, medical …

Background: Topical glucocorticoids (more commonly termed topical corticosteroids; TCS)
are first-line therapies for management of numerous skin conditions. Topical Steroid …

To the Editor: Atopic dermatitis (AD) affects 16.5% of children and 7.3% of adults in the United
States, resulting in negative physical, mental, social, and financial consequences. 1-3 In …

Discussion: BPDCN is a rare hematologic neoplasm with a poor prognosis. Its initial
presentation usually consists of skin lesions that simulate hematomas, as occurred in our patient. …

Since their introduction, topical corticosteroids (TCs) have become a mainstay in treatment
of many inflammatory and autoimmune conditions. Their clinical effects are mediated by anti-…